Modelling & Simulation SIG

The Modelling and Simulation Special Interest Group is a forum to share knowledge and understanding about statistical modelling and simulation related to pharmaceutical development.

Publications:

  • Predictive event modelling in multicenter clinical trials with waiting time to response, Vladimir V. Anisimov DOI: 10.1002/pst.525 Pharmaceutical Statistics Special Issue: Focusing on the PSI Special Interest Groups Volume 10, Issue 6, pages 517–522, November/December 2011
  • Modelling and simulation in the pharmaceutical industry—some reflections, Carl-Fredrik Burman, Stig Johan Wiklund DOI: 10.1002/pst.523 Pharmaceutical Statistics Special Issue: Focusing on the PSI Special Interest Groups Volume 10, Issue 6, pages 508–516, November/December 2011
  • V. Anisimov, Effects of unstratified and centre-stratified randomization in multicentre clinical trials, Pharmaceutical Statistics, v. 10, iss. 1, 2011, pp. 50-59.
  • V. Anisimov, Drug supply modeling in clinical trials (statistical methodology), Pharmaceutical Outsourcing, May/June, 2010, pp. 50-55.
  • V. Anisimov, Predictive modelling of recruitment and drug supply in multicenter clinical trials, Proc. of the Joint Statistical Meeting, Washington, USA, August, 2009, pp. 1248-1259.
  • V. Anisimov, Recruitment modeling and predicting in clinical trials, Pharmaceutical Outsourcing, March/April 2009, Vol. 10, Issue 1, pp. 44-48.
  • V. Anisimov, Effects of unstratified and centre-stratified randomization in multicentre clinical trials, Pharmaceutical Statistics v.10, iss. 1, 2011, pp.50-59
  • V. Anisimov, Impact of stratified randomization in clinical trials, In: Giovagnoli A., Atkinson AC., Torsney B. (Eds), MODA 9 - Advances in Model-Oriented Design and Analysis. Physica-Verlag/Springer, Berlin, 2010, pp. 1-8.
  • S. Senn, V. Anisimov, V. Fedorov, Comparisons of minimisation and Atkinson's algorithm, Statistics in Medicine, 2010, V. 29, issue 7/8, pp. 721-730.
  • V. Anisimov, V. Fedorov, Modeling, prediction and adaptive adjustment of recruitment in multicentre trials, Statistics in Medicine, v. 26, No 27, 2007, pp. 4958-4975.

Coming soon:

Autumn 2014 - Making Modelling and Simulation Work for Regulators and Industry: This one day meeting will be a forum for examining how industry can best present our model-derived predictions to regulators.

External Links:

Recent Activity

Latest News


Show all news

EventsFuture Events


  • Patient Engagement in Clinical Trials Webinar - Dates: 13 – 13 Jun, 2017

    Following on from the successful and thought-provoking presentation at last year’s PSI conference by Paul Wicks from PatientsLikeMe, this webinar will continue to explore the ways in which patients are influencing the design of new clinical trials.
  • BBS / PSI One-day Event on Cancer Immunotherapy - Dates: 15 Jun, 2017

    This joint Basel Biometric Society / PSI one day meeting will present an overview of the science and potential statistical challenges across a range of topics covering early and late phases of development, regulatory and health technology assessments.
Merck Logo2

Associate Director, Biostatistician

read more...

Leeds-80x250

Medical Statistician / Senior Medical Statistician

read more...

Astrazeneca

Associate Director, Statistics Team leader - Early Clinical Development

read more...

Astrazeneca

Early Clinical Development – various levels

read more...

LOGO

Biostatistics Head of Department

read more...

Astrazeneca

Principal Statistician – Centralised Statistical Monitoring

read more...

Astrazeneca

Clinical Trial Design Methodology Expert - Statistical Innovation Team

read more...